nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—AGTR1—asthma	0.434	0.809	CbGaD
Valsartan—ALB—asthma	0.103	0.191	CbGaD
Valsartan—CYP2C9—Zileuton—asthma	0.0305	0.155	CbGbCtD
Valsartan—CYP2C9—Zafirlukast—asthma	0.0268	0.137	CbGbCtD
Valsartan—CYP2C9—Formoterol—asthma	0.0259	0.132	CbGbCtD
Valsartan—CYP2C9—Arformoterol—asthma	0.0259	0.132	CbGbCtD
Valsartan—CYP2C9—Theophylline—asthma	0.0207	0.106	CbGbCtD
Valsartan—ALB—Prednisone—asthma	0.0202	0.103	CbGbCtD
Valsartan—CYP2C9—Montelukast—asthma	0.0196	0.1	CbGbCtD
Valsartan—CYP2C9—Loratadine—asthma	0.0196	0.1	CbGbCtD
Valsartan—CYP2C9—Dexamethasone—asthma	0.00679	0.0346	CbGbCtD
Valsartan—Tasosartan—AGTR2—asthma	0.00213	0.341	CrCbGaD
Valsartan—Forasartan—AGTR1—asthma	0.00122	0.195	CrCbGaD
Valsartan—Tasosartan—AGTR1—asthma	0.000737	0.118	CrCbGaD
Valsartan—Olmesartan—AGTR1—asthma	0.000623	0.0998	CrCbGaD
Valsartan—Irbesartan—AGTR1—asthma	0.000484	0.0776	CrCbGaD
Valsartan—Candesartan—AGTR1—asthma	0.000484	0.0776	CrCbGaD
Valsartan—Losartan—AGTR1—asthma	0.000312	0.05	CrCbGaD
Valsartan—Losartan—ACE—asthma	0.00018	0.0289	CrCbGaD
Valsartan—Losartan—ALB—asthma	7.39e-05	0.0118	CrCbGaD
Valsartan—Headache—Formoterol—asthma	6.62e-05	0.000346	CcSEcCtD
Valsartan—Diarrhoea—Budesonide—asthma	6.61e-05	0.000346	CcSEcCtD
Valsartan—Vision blurred—Prednisolone—asthma	6.61e-05	0.000346	CcSEcCtD
Valsartan—Dizziness—Salbutamol—asthma	6.6e-05	0.000345	CcSEcCtD
Valsartan—Vomiting—Montelukast—asthma	6.58e-05	0.000344	CcSEcCtD
Valsartan—Rash—Montelukast—asthma	6.52e-05	0.000341	CcSEcCtD
Valsartan—Dermatitis—Montelukast—asthma	6.52e-05	0.000341	CcSEcCtD
Valsartan—Headache—Montelukast—asthma	6.48e-05	0.000339	CcSEcCtD
Valsartan—Mental disorder—Methylprednisolone—asthma	6.47e-05	0.000339	CcSEcCtD
Valsartan—Malnutrition—Methylprednisolone—asthma	6.43e-05	0.000337	CcSEcCtD
Valsartan—Angioedema—Prednisolone—asthma	6.4e-05	0.000335	CcSEcCtD
Valsartan—Dizziness—Budesonide—asthma	6.39e-05	0.000334	CcSEcCtD
Valsartan—Vomiting—Salbutamol—asthma	6.34e-05	0.000332	CcSEcCtD
Valsartan—Dysgeusia—Triamcinolone—asthma	6.31e-05	0.00033	CcSEcCtD
Valsartan—Vertigo—Prednisolone—asthma	6.3e-05	0.00033	CcSEcCtD
Valsartan—Rash—Salbutamol—asthma	6.29e-05	0.000329	CcSEcCtD
Valsartan—Syncope—Prednisolone—asthma	6.29e-05	0.000329	CcSEcCtD
Valsartan—Dermatitis—Salbutamol—asthma	6.28e-05	0.000329	CcSEcCtD
Valsartan—Nausea—Formoterol—asthma	6.27e-05	0.000328	CcSEcCtD
Valsartan—Nausea—Arformoterol—asthma	6.27e-05	0.000328	CcSEcCtD
Valsartan—Angioedema—Hydrocortisone—asthma	6.25e-05	0.000327	CcSEcCtD
Valsartan—Headache—Salbutamol—asthma	6.25e-05	0.000327	CcSEcCtD
Valsartan—Back pain—Triamcinolone—asthma	6.23e-05	0.000326	CcSEcCtD
Valsartan—Loss of consciousness—Prednisolone—asthma	6.16e-05	0.000322	CcSEcCtD
Valsartan—Vertigo—Hydrocortisone—asthma	6.15e-05	0.000322	CcSEcCtD
Valsartan—Nausea—Montelukast—asthma	6.15e-05	0.000322	CcSEcCtD
Valsartan—Vomiting—Budesonide—asthma	6.14e-05	0.000321	CcSEcCtD
Valsartan—Syncope—Hydrocortisone—asthma	6.14e-05	0.000321	CcSEcCtD
Valsartan—Angiopathy—Dexamethasone—asthma	6.1e-05	0.000319	CcSEcCtD
Valsartan—Angiopathy—Betamethasone—asthma	6.1e-05	0.000319	CcSEcCtD
Valsartan—Rash—Budesonide—asthma	6.09e-05	0.000319	CcSEcCtD
Valsartan—Dermatitis—Budesonide—asthma	6.09e-05	0.000318	CcSEcCtD
Valsartan—Headache—Budesonide—asthma	6.05e-05	0.000317	CcSEcCtD
Valsartan—Loss of consciousness—Hydrocortisone—asthma	6.02e-05	0.000315	CcSEcCtD
Valsartan—Alopecia—Betamethasone—asthma	5.94e-05	0.000311	CcSEcCtD
Valsartan—Alopecia—Dexamethasone—asthma	5.94e-05	0.000311	CcSEcCtD
Valsartan—Nausea—Salbutamol—asthma	5.92e-05	0.00031	CcSEcCtD
Valsartan—Angioedema—Triamcinolone—asthma	5.89e-05	0.000308	CcSEcCtD
Valsartan—Haemoglobin—Prednisone—asthma	5.88e-05	0.000308	CcSEcCtD
Valsartan—Angioedema—Methylprednisolone—asthma	5.88e-05	0.000308	CcSEcCtD
Valsartan—Haemorrhage—Prednisone—asthma	5.85e-05	0.000306	CcSEcCtD
Valsartan—Myalgia—Hydrocortisone—asthma	5.83e-05	0.000305	CcSEcCtD
Valsartan—Anxiety—Hydrocortisone—asthma	5.81e-05	0.000304	CcSEcCtD
Valsartan—Vertigo—Triamcinolone—asthma	5.79e-05	0.000303	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.79e-05	0.000303	CcSEcCtD
Valsartan—Syncope—Triamcinolone—asthma	5.78e-05	0.000302	CcSEcCtD
Valsartan—Vertigo—Methylprednisolone—asthma	5.78e-05	0.000302	CcSEcCtD
Valsartan—Syncope—Methylprednisolone—asthma	5.77e-05	0.000302	CcSEcCtD
Valsartan—Connective tissue disorder—Prednisone—asthma	5.75e-05	0.000301	CcSEcCtD
Valsartan—Nausea—Budesonide—asthma	5.74e-05	0.0003	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisolone—asthma	5.72e-05	0.000299	CcSEcCtD
Valsartan—Oedema—Prednisolone—asthma	5.72e-05	0.000299	CcSEcCtD
Valsartan—Loss of consciousness—Triamcinolone—asthma	5.67e-05	0.000296	CcSEcCtD
Valsartan—Loss of consciousness—Methylprednisolone—asthma	5.65e-05	0.000296	CcSEcCtD
Valsartan—Shock—Prednisolone—asthma	5.63e-05	0.000294	CcSEcCtD
Valsartan—Cough—Triamcinolone—asthma	5.62e-05	0.000294	CcSEcCtD
Valsartan—Oedema—Hydrocortisone—asthma	5.59e-05	0.000292	CcSEcCtD
Valsartan—Anaphylactic shock—Hydrocortisone—asthma	5.59e-05	0.000292	CcSEcCtD
Valsartan—Infection—Hydrocortisone—asthma	5.55e-05	0.00029	CcSEcCtD
Valsartan—Shock—Hydrocortisone—asthma	5.5e-05	0.000288	CcSEcCtD
Valsartan—Myalgia—Triamcinolone—asthma	5.49e-05	0.000287	CcSEcCtD
Valsartan—Nervous system disorder—Hydrocortisone—asthma	5.48e-05	0.000287	CcSEcCtD
Valsartan—Myalgia—Methylprednisolone—asthma	5.48e-05	0.000287	CcSEcCtD
Valsartan—Arthralgia—Methylprednisolone—asthma	5.48e-05	0.000287	CcSEcCtD
Valsartan—Anxiety—Methylprednisolone—asthma	5.46e-05	0.000286	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.44e-05	0.000285	CcSEcCtD
Valsartan—Skin disorder—Hydrocortisone—asthma	5.43e-05	0.000284	CcSEcCtD
Valsartan—Dry mouth—Triamcinolone—asthma	5.37e-05	0.000281	CcSEcCtD
Valsartan—Angioedema—Betamethasone—asthma	5.34e-05	0.00028	CcSEcCtD
Valsartan—Angioedema—Dexamethasone—asthma	5.34e-05	0.00028	CcSEcCtD
Valsartan—Anorexia—Hydrocortisone—asthma	5.33e-05	0.000279	CcSEcCtD
Valsartan—Angiopathy—Prednisone—asthma	5.31e-05	0.000278	CcSEcCtD
Valsartan—Immune system disorder—Prednisone—asthma	5.28e-05	0.000277	CcSEcCtD
Valsartan—Anaphylactic shock—Triamcinolone—asthma	5.26e-05	0.000275	CcSEcCtD
Valsartan—Oedema—Triamcinolone—asthma	5.26e-05	0.000275	CcSEcCtD
Valsartan—Vertigo—Betamethasone—asthma	5.25e-05	0.000275	CcSEcCtD
Valsartan—Vertigo—Dexamethasone—asthma	5.25e-05	0.000275	CcSEcCtD
Valsartan—Anaphylactic shock—Methylprednisolone—asthma	5.25e-05	0.000275	CcSEcCtD
Valsartan—Syncope—Dexamethasone—asthma	5.24e-05	0.000274	CcSEcCtD
Valsartan—Syncope—Betamethasone—asthma	5.24e-05	0.000274	CcSEcCtD
Valsartan—Infection—Triamcinolone—asthma	5.23e-05	0.000273	CcSEcCtD
Valsartan—Hypotension—Hydrocortisone—asthma	5.22e-05	0.000273	CcSEcCtD
Valsartan—Infection—Methylprednisolone—asthma	5.21e-05	0.000273	CcSEcCtD
Valsartan—Shock—Triamcinolone—asthma	5.18e-05	0.000271	CcSEcCtD
Valsartan—Insomnia—Prednisolone—asthma	5.17e-05	0.000271	CcSEcCtD
Valsartan—Alopecia—Prednisone—asthma	5.17e-05	0.000271	CcSEcCtD
Valsartan—Shock—Methylprednisolone—asthma	5.16e-05	0.00027	CcSEcCtD
Valsartan—Nervous system disorder—Methylprednisolone—asthma	5.15e-05	0.000269	CcSEcCtD
Valsartan—Loss of consciousness—Dexamethasone—asthma	5.14e-05	0.000269	CcSEcCtD
Valsartan—Loss of consciousness—Betamethasone—asthma	5.14e-05	0.000269	CcSEcCtD
Valsartan—Paraesthesia—Prednisolone—asthma	5.14e-05	0.000269	CcSEcCtD
Valsartan—Mental disorder—Prednisone—asthma	5.13e-05	0.000268	CcSEcCtD
Valsartan—Skin disorder—Methylprednisolone—asthma	5.1e-05	0.000267	CcSEcCtD
Valsartan—Malnutrition—Prednisone—asthma	5.09e-05	0.000267	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Hydrocortisone—asthma	5.09e-05	0.000266	CcSEcCtD
Valsartan—Insomnia—Hydrocortisone—asthma	5.05e-05	0.000264	CcSEcCtD
Valsartan—Paraesthesia—Hydrocortisone—asthma	5.02e-05	0.000263	CcSEcCtD
Valsartan—Myalgia—Dexamethasone—asthma	4.98e-05	0.000261	CcSEcCtD
Valsartan—Myalgia—Betamethasone—asthma	4.98e-05	0.000261	CcSEcCtD
Valsartan—Anxiety—Dexamethasone—asthma	4.96e-05	0.00026	CcSEcCtD
Valsartan—Anxiety—Betamethasone—asthma	4.96e-05	0.00026	CcSEcCtD
Valsartan—Dyspepsia—Hydrocortisone—asthma	4.92e-05	0.000257	CcSEcCtD
Valsartan—Hypotension—Methylprednisolone—asthma	4.9e-05	0.000257	CcSEcCtD
Valsartan—Decreased appetite—Hydrocortisone—asthma	4.86e-05	0.000254	CcSEcCtD
Valsartan—Gastrointestinal disorder—Hydrocortisone—asthma	4.82e-05	0.000252	CcSEcCtD
Valsartan—Fatigue—Hydrocortisone—asthma	4.82e-05	0.000252	CcSEcCtD
Valsartan—Vision blurred—Prednisone—asthma	4.8e-05	0.000251	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Triamcinolone—asthma	4.79e-05	0.000251	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methylprednisolone—asthma	4.78e-05	0.00025	CcSEcCtD
Valsartan—Oedema—Betamethasone—asthma	4.77e-05	0.00025	CcSEcCtD
Valsartan—Anaphylactic shock—Betamethasone—asthma	4.77e-05	0.00025	CcSEcCtD
Valsartan—Anaphylactic shock—Dexamethasone—asthma	4.77e-05	0.00025	CcSEcCtD
Valsartan—Oedema—Dexamethasone—asthma	4.77e-05	0.00025	CcSEcCtD
Valsartan—Insomnia—Triamcinolone—asthma	4.76e-05	0.000249	CcSEcCtD
Valsartan—Insomnia—Methylprednisolone—asthma	4.75e-05	0.000248	CcSEcCtD
Valsartan—Infection—Dexamethasone—asthma	4.74e-05	0.000248	CcSEcCtD
Valsartan—Infection—Betamethasone—asthma	4.74e-05	0.000248	CcSEcCtD
Valsartan—Paraesthesia—Triamcinolone—asthma	4.72e-05	0.000247	CcSEcCtD
Valsartan—Paraesthesia—Methylprednisolone—asthma	4.71e-05	0.000247	CcSEcCtD
Valsartan—Shock—Dexamethasone—asthma	4.7e-05	0.000246	CcSEcCtD
Valsartan—Shock—Betamethasone—asthma	4.7e-05	0.000246	CcSEcCtD
Valsartan—Dyspnoea—Triamcinolone—asthma	4.69e-05	0.000245	CcSEcCtD
Valsartan—Nervous system disorder—Dexamethasone—asthma	4.68e-05	0.000245	CcSEcCtD
Valsartan—Nervous system disorder—Betamethasone—asthma	4.68e-05	0.000245	CcSEcCtD
Valsartan—Thrombocytopenia—Dexamethasone—asthma	4.67e-05	0.000245	CcSEcCtD
Valsartan—Thrombocytopenia—Betamethasone—asthma	4.67e-05	0.000245	CcSEcCtD
Valsartan—Angioedema—Prednisone—asthma	4.65e-05	0.000244	CcSEcCtD
Valsartan—Dyspepsia—Triamcinolone—asthma	4.63e-05	0.000242	CcSEcCtD
Valsartan—Dyspepsia—Methylprednisolone—asthma	4.62e-05	0.000242	CcSEcCtD
Valsartan—Vertigo—Prednisone—asthma	4.58e-05	0.000239	CcSEcCtD
Valsartan—Gastrointestinal pain—Hydrocortisone—asthma	4.57e-05	0.000239	CcSEcCtD
Valsartan—Syncope—Prednisone—asthma	4.57e-05	0.000239	CcSEcCtD
Valsartan—Anorexia—Betamethasone—asthma	4.55e-05	0.000238	CcSEcCtD
Valsartan—Anorexia—Dexamethasone—asthma	4.55e-05	0.000238	CcSEcCtD
Valsartan—Urticaria—Prednisolone—asthma	4.54e-05	0.000238	CcSEcCtD
Valsartan—Fatigue—Triamcinolone—asthma	4.54e-05	0.000237	CcSEcCtD
Valsartan—Fatigue—Methylprednisolone—asthma	4.53e-05	0.000237	CcSEcCtD
Valsartan—Loss of consciousness—Prednisone—asthma	4.48e-05	0.000234	CcSEcCtD
Valsartan—Hypotension—Dexamethasone—asthma	4.46e-05	0.000233	CcSEcCtD
Valsartan—Hypotension—Betamethasone—asthma	4.46e-05	0.000233	CcSEcCtD
Valsartan—Urticaria—Hydrocortisone—asthma	4.44e-05	0.000232	CcSEcCtD
Valsartan—Abdominal pain—Hydrocortisone—asthma	4.42e-05	0.000231	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Betamethasone—asthma	4.35e-05	0.000228	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dexamethasone—asthma	4.35e-05	0.000228	CcSEcCtD
Valsartan—Myalgia—Prednisone—asthma	4.34e-05	0.000227	CcSEcCtD
Valsartan—Arthralgia—Prednisone—asthma	4.34e-05	0.000227	CcSEcCtD
Valsartan—Anxiety—Prednisone—asthma	4.32e-05	0.000226	CcSEcCtD
Valsartan—Insomnia—Dexamethasone—asthma	4.32e-05	0.000226	CcSEcCtD
Valsartan—Insomnia—Betamethasone—asthma	4.32e-05	0.000226	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.31e-05	0.000225	CcSEcCtD
Valsartan—Gastrointestinal pain—Methylprednisolone—asthma	4.29e-05	0.000225	CcSEcCtD
Valsartan—Paraesthesia—Betamethasone—asthma	4.29e-05	0.000224	CcSEcCtD
Valsartan—Paraesthesia—Dexamethasone—asthma	4.29e-05	0.000224	CcSEcCtD
Valsartan—Hypersensitivity—Prednisolone—asthma	4.21e-05	0.000221	CcSEcCtD
Valsartan—Dyspepsia—Betamethasone—asthma	4.2e-05	0.00022	CcSEcCtD
Valsartan—Dyspepsia—Dexamethasone—asthma	4.2e-05	0.00022	CcSEcCtD
Valsartan—Urticaria—Triamcinolone—asthma	4.18e-05	0.000219	CcSEcCtD
Valsartan—Urticaria—Methylprednisolone—asthma	4.17e-05	0.000218	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisone—asthma	4.16e-05	0.000218	CcSEcCtD
Valsartan—Oedema—Prednisone—asthma	4.16e-05	0.000218	CcSEcCtD
Valsartan—Abdominal pain—Methylprednisolone—asthma	4.15e-05	0.000217	CcSEcCtD
Valsartan—Decreased appetite—Dexamethasone—asthma	4.15e-05	0.000217	CcSEcCtD
Valsartan—Decreased appetite—Betamethasone—asthma	4.15e-05	0.000217	CcSEcCtD
Valsartan—Infection—Prednisone—asthma	4.13e-05	0.000216	CcSEcCtD
Valsartan—Gastrointestinal disorder—Betamethasone—asthma	4.12e-05	0.000216	CcSEcCtD
Valsartan—Gastrointestinal disorder—Dexamethasone—asthma	4.12e-05	0.000216	CcSEcCtD
Valsartan—Hypersensitivity—Hydrocortisone—asthma	4.12e-05	0.000215	CcSEcCtD
Valsartan—Fatigue—Dexamethasone—asthma	4.12e-05	0.000215	CcSEcCtD
Valsartan—Fatigue—Betamethasone—asthma	4.12e-05	0.000215	CcSEcCtD
Valsartan—Shock—Prednisone—asthma	4.09e-05	0.000214	CcSEcCtD
Valsartan—Nervous system disorder—Prednisone—asthma	4.08e-05	0.000213	CcSEcCtD
Valsartan—Skin disorder—Prednisone—asthma	4.04e-05	0.000211	CcSEcCtD
Valsartan—Asthenia—Hydrocortisone—asthma	4.01e-05	0.00021	CcSEcCtD
Valsartan—Anorexia—Prednisone—asthma	3.96e-05	0.000207	CcSEcCtD
Valsartan—Pruritus—Hydrocortisone—asthma	3.95e-05	0.000207	CcSEcCtD
Valsartan—Gastrointestinal pain—Betamethasone—asthma	3.9e-05	0.000204	CcSEcCtD
Valsartan—Gastrointestinal pain—Dexamethasone—asthma	3.9e-05	0.000204	CcSEcCtD
Valsartan—Hypersensitivity—Triamcinolone—asthma	3.88e-05	0.000203	CcSEcCtD
Valsartan—Hypersensitivity—Methylprednisolone—asthma	3.87e-05	0.000202	CcSEcCtD
Valsartan—Diarrhoea—Hydrocortisone—asthma	3.82e-05	0.0002	CcSEcCtD
Valsartan—Urticaria—Dexamethasone—asthma	3.79e-05	0.000198	CcSEcCtD
Valsartan—Urticaria—Betamethasone—asthma	3.79e-05	0.000198	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Prednisone—asthma	3.79e-05	0.000198	CcSEcCtD
Valsartan—Dizziness—Prednisolone—asthma	3.78e-05	0.000198	CcSEcCtD
Valsartan—Asthenia—Triamcinolone—asthma	3.77e-05	0.000198	CcSEcCtD
Valsartan—Abdominal pain—Betamethasone—asthma	3.77e-05	0.000197	CcSEcCtD
Valsartan—Abdominal pain—Dexamethasone—asthma	3.77e-05	0.000197	CcSEcCtD
Valsartan—Asthenia—Methylprednisolone—asthma	3.77e-05	0.000197	CcSEcCtD
Valsartan—Insomnia—Prednisone—asthma	3.76e-05	0.000197	CcSEcCtD
Valsartan—Paraesthesia—Prednisone—asthma	3.73e-05	0.000195	CcSEcCtD
Valsartan—Pruritus—Triamcinolone—asthma	3.72e-05	0.000195	CcSEcCtD
Valsartan—Pruritus—Methylprednisolone—asthma	3.71e-05	0.000194	CcSEcCtD
Valsartan—Dizziness—Hydrocortisone—asthma	3.69e-05	0.000193	CcSEcCtD
Valsartan—Dyspepsia—Prednisone—asthma	3.66e-05	0.000191	CcSEcCtD
Valsartan—Decreased appetite—Prednisone—asthma	3.61e-05	0.000189	CcSEcCtD
Valsartan—Rash—Prednisolone—asthma	3.61e-05	0.000189	CcSEcCtD
Valsartan—Dermatitis—Prednisolone—asthma	3.6e-05	0.000189	CcSEcCtD
Valsartan—Diarrhoea—Methylprednisolone—asthma	3.59e-05	0.000188	CcSEcCtD
Valsartan—Fatigue—Prednisone—asthma	3.58e-05	0.000188	CcSEcCtD
Valsartan—Headache—Prednisolone—asthma	3.58e-05	0.000188	CcSEcCtD
Valsartan—Constipation—Prednisone—asthma	3.55e-05	0.000186	CcSEcCtD
Valsartan—Vomiting—Hydrocortisone—asthma	3.55e-05	0.000186	CcSEcCtD
Valsartan—Rash—Hydrocortisone—asthma	3.52e-05	0.000184	CcSEcCtD
Valsartan—Dermatitis—Hydrocortisone—asthma	3.52e-05	0.000184	CcSEcCtD
Valsartan—Headache—Hydrocortisone—asthma	3.5e-05	0.000183	CcSEcCtD
Valsartan—Dizziness—Triamcinolone—asthma	3.48e-05	0.000182	CcSEcCtD
Valsartan—Dizziness—Methylprednisolone—asthma	3.47e-05	0.000182	CcSEcCtD
Valsartan—Asthenia—Betamethasone—asthma	3.42e-05	0.000179	CcSEcCtD
Valsartan—Asthenia—Dexamethasone—asthma	3.42e-05	0.000179	CcSEcCtD
Valsartan—Gastrointestinal pain—Prednisone—asthma	3.4e-05	0.000178	CcSEcCtD
Valsartan—Nausea—Prednisolone—asthma	3.4e-05	0.000178	CcSEcCtD
Valsartan—Pruritus—Betamethasone—asthma	3.38e-05	0.000177	CcSEcCtD
Valsartan—Pruritus—Dexamethasone—asthma	3.38e-05	0.000177	CcSEcCtD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—asthma	3.37e-05	0.000483	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—CSF2—asthma	3.36e-05	0.000483	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—GSTM1—asthma	3.35e-05	0.000482	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—EDN1—asthma	3.35e-05	0.00048	CbGpPWpGaD
Valsartan—Vomiting—Triamcinolone—asthma	3.34e-05	0.000175	CcSEcCtD
Valsartan—SLCO1B3—Metabolism—ALOX5—asthma	3.34e-05	0.00048	CbGpPWpGaD
Valsartan—Vomiting—Methylprednisolone—asthma	3.34e-05	0.000175	CcSEcCtD
Valsartan—SLCO1B1—Metabolism—ALDH7A1—asthma	3.32e-05	0.000477	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCL5—asthma	3.32e-05	0.000477	CbGpPWpGaD
Valsartan—Nausea—Hydrocortisone—asthma	3.32e-05	0.000174	CcSEcCtD
Valsartan—Rash—Triamcinolone—asthma	3.32e-05	0.000174	CcSEcCtD
Valsartan—AGTR1—Signaling Pathways—IL2RB—asthma	3.31e-05	0.000476	CbGpPWpGaD
Valsartan—Dermatitis—Triamcinolone—asthma	3.31e-05	0.000173	CcSEcCtD
Valsartan—Rash—Methylprednisolone—asthma	3.31e-05	0.000173	CcSEcCtD
Valsartan—Dermatitis—Methylprednisolone—asthma	3.31e-05	0.000173	CcSEcCtD
Valsartan—Urticaria—Prednisone—asthma	3.3e-05	0.000173	CcSEcCtD
Valsartan—Headache—Triamcinolone—asthma	3.3e-05	0.000172	CcSEcCtD
Valsartan—Headache—Methylprednisolone—asthma	3.29e-05	0.000172	CcSEcCtD
Valsartan—Abdominal pain—Prednisone—asthma	3.29e-05	0.000172	CcSEcCtD
Valsartan—AGTR1—Signaling Pathways—PDE4D—asthma	3.29e-05	0.000472	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2RB—asthma	3.27e-05	0.00047	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MYB—asthma	3.27e-05	0.00047	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CSF2—asthma	3.27e-05	0.000469	CbGpPWpGaD
Valsartan—Diarrhoea—Dexamethasone—asthma	3.27e-05	0.000171	CcSEcCtD
Valsartan—Diarrhoea—Betamethasone—asthma	3.27e-05	0.000171	CcSEcCtD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—asthma	3.24e-05	0.000466	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CHAT—asthma	3.23e-05	0.000464	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ITPR1—asthma	3.22e-05	0.000462	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDE4B—asthma	3.2e-05	0.00046	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—C5—asthma	3.2e-05	0.00046	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TACR1—asthma	3.2e-05	0.00046	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCL8—asthma	3.2e-05	0.000459	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	3.19e-05	0.000458	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CARM1—asthma	3.19e-05	0.000457	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ARG2—asthma	3.19e-05	0.000457	CbGpPWpGaD
Valsartan—Dizziness—Betamethasone—asthma	3.16e-05	0.000165	CcSEcCtD
Valsartan—Dizziness—Dexamethasone—asthma	3.16e-05	0.000165	CcSEcCtD
Valsartan—SLCO1B3—Metabolism—DCN—asthma	3.14e-05	0.000451	CbGpPWpGaD
Valsartan—Nausea—Triamcinolone—asthma	3.12e-05	0.000164	CcSEcCtD
Valsartan—ALB—Platelet degranulation—TGFB1—asthma	3.12e-05	0.000449	CbGpPWpGaD
Valsartan—Nausea—Methylprednisolone—asthma	3.12e-05	0.000163	CcSEcCtD
Valsartan—Hypersensitivity—Prednisone—asthma	3.06e-05	0.00016	CcSEcCtD
Valsartan—SLCO1B3—Metabolism—ALDH2—asthma	3.06e-05	0.000439	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EDN1—asthma	3.04e-05	0.000436	CbGpPWpGaD
Valsartan—Vomiting—Betamethasone—asthma	3.03e-05	0.000159	CcSEcCtD
Valsartan—Vomiting—Dexamethasone—asthma	3.03e-05	0.000159	CcSEcCtD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2RA—asthma	3.03e-05	0.000435	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL5—asthma	3.01e-05	0.000433	CbGpPWpGaD
Valsartan—Rash—Betamethasone—asthma	3.01e-05	0.000157	CcSEcCtD
Valsartan—Rash—Dexamethasone—asthma	3.01e-05	0.000157	CcSEcCtD
Valsartan—Dermatitis—Betamethasone—asthma	3.01e-05	0.000157	CcSEcCtD
Valsartan—Dermatitis—Dexamethasone—asthma	3.01e-05	0.000157	CcSEcCtD
Valsartan—AGTR1—Signaling by GPCR—PLA2G4A—asthma	3e-05	0.000431	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCR5—asthma	2.99e-05	0.000429	CbGpPWpGaD
Valsartan—Headache—Betamethasone—asthma	2.99e-05	0.000156	CcSEcCtD
Valsartan—Headache—Dexamethasone—asthma	2.99e-05	0.000156	CcSEcCtD
Valsartan—Asthenia—Prednisone—asthma	2.98e-05	0.000156	CcSEcCtD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—asthma	2.98e-05	0.000427	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINA1—asthma	2.97e-05	0.000427	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CSF2—asthma	2.97e-05	0.000426	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2RA—asthma	2.95e-05	0.000423	CbGpPWpGaD
Valsartan—Pruritus—Prednisone—asthma	2.94e-05	0.000154	CcSEcCtD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—asthma	2.94e-05	0.000422	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR3—asthma	2.93e-05	0.00042	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PDGFB—asthma	2.92e-05	0.00042	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—C3—asthma	2.92e-05	0.00042	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTT1—asthma	2.91e-05	0.000417	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.88e-05	0.000413	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPY—asthma	2.85e-05	0.00041	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—asthma	2.85e-05	0.000409	CbGpPWpGaD
Valsartan—Diarrhoea—Prednisone—asthma	2.84e-05	0.000149	CcSEcCtD
Valsartan—Nausea—Dexamethasone—asthma	2.84e-05	0.000148	CcSEcCtD
Valsartan—Nausea—Betamethasone—asthma	2.84e-05	0.000148	CcSEcCtD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.79e-05	0.000401	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	2.77e-05	0.000398	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	2.77e-05	0.000398	CbGpPWpGaD
Valsartan—ALB—Metabolism—LTC4S—asthma	2.77e-05	0.000398	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PPP2CA—asthma	2.77e-05	0.000397	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AGTR2—asthma	2.75e-05	0.000395	CbGpPWpGaD
Valsartan—Dizziness—Prednisone—asthma	2.75e-05	0.000144	CcSEcCtD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CARM1—asthma	2.75e-05	0.000394	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—asthma	2.75e-05	0.000394	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCR5—asthma	2.72e-05	0.00039	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—asthma	2.7e-05	0.000388	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—asthma	2.68e-05	0.000384	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2RA—asthma	2.68e-05	0.000384	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—C3—asthma	2.65e-05	0.000381	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	2.64e-05	0.00038	CbGpPWpGaD
Valsartan—Vomiting—Prednisone—asthma	2.64e-05	0.000138	CcSEcCtD
Valsartan—SLCO1B1—Metabolism—ALOX5AP—asthma	2.64e-05	0.000379	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALOX15—asthma	2.64e-05	0.000379	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—FN1—asthma	2.64e-05	0.000379	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EDNRB—asthma	2.64e-05	0.000378	CbGpPWpGaD
Valsartan—Rash—Prednisone—asthma	2.62e-05	0.000137	CcSEcCtD
Valsartan—Dermatitis—Prednisone—asthma	2.62e-05	0.000137	CcSEcCtD
Valsartan—ALB—Transmembrane transport of small molecules—CARM1—asthma	2.61e-05	0.000375	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TAC1—asthma	2.61e-05	0.000375	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPS—asthma	2.61e-05	0.000375	CbGpPWpGaD
Valsartan—Headache—Prednisone—asthma	2.6e-05	0.000136	CcSEcCtD
Valsartan—AGTR1—Signaling Pathways—CXCR3—asthma	2.56e-05	0.000367	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—asthma	2.55e-05	0.000366	CbGpPWpGaD
Valsartan—ALB—Hemostasis—GATA3—asthma	2.53e-05	0.000363	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CHAT—asthma	2.52e-05	0.000361	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CYBA—asthma	2.48e-05	0.000356	CbGpPWpGaD
Valsartan—Nausea—Prednisone—asthma	2.47e-05	0.000129	CcSEcCtD
Valsartan—AGTR1—Signaling Pathways—PARP1—asthma	2.43e-05	0.000348	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL5—asthma	2.43e-05	0.000348	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NQO1—asthma	2.42e-05	0.000347	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—POMC—asthma	2.4e-05	0.000345	CbGpPWpGaD
Valsartan—ALB—Metabolism—LTA4H—asthma	2.4e-05	0.000345	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL5—asthma	2.4e-05	0.000344	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADCY2—asthma	2.36e-05	0.000339	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.36e-05	0.000338	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.34e-05	0.000336	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—BDKRB2—asthma	2.34e-05	0.000336	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—POMC—asthma	2.34e-05	0.000336	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LTC4S—asthma	2.27e-05	0.000325	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADCY2—asthma	2.26e-05	0.000325	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL3—asthma	2.26e-05	0.000324	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS1—asthma	2.25e-05	0.000324	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	2.25e-05	0.000323	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALOX5—asthma	2.24e-05	0.000322	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL3—asthma	2.23e-05	0.00032	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—asthma	2.2e-05	0.000315	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—asthma	2.18e-05	0.000313	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CARM1—asthma	2.14e-05	0.000307	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—KNG1—asthma	2.13e-05	0.000306	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—POMC—asthma	2.12e-05	0.000305	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—RHOA—asthma	2.12e-05	0.000304	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DCN—asthma	2.11e-05	0.000303	CbGpPWpGaD
Valsartan—ALB—Hemostasis—KNG1—asthma	2.1e-05	0.000302	CbGpPWpGaD
Valsartan—ALB—Metabolism—ARG1—asthma	2.1e-05	0.000301	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL2—asthma	2.08e-05	0.000298	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6R—asthma	2.07e-05	0.000297	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL10—asthma	2.07e-05	0.000297	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—RHOA—asthma	2.06e-05	0.000296	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALDH2—asthma	2.05e-05	0.000295	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—asthma	2.04e-05	0.000293	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NTRK1—asthma	2.03e-05	0.000291	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTP1—asthma	2.01e-05	0.000289	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRB2—asthma	2.01e-05	0.000288	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HMOX1—asthma	1.99e-05	0.000285	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ITPR1—asthma	1.98e-05	0.000285	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—asthma	1.97e-05	0.000283	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LTA4H—asthma	1.97e-05	0.000282	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAT—asthma	1.96e-05	0.000281	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTT1—asthma	1.95e-05	0.00028	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ADCY2—asthma	1.94e-05	0.000278	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ITPR1—asthma	1.9e-05	0.000273	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALDH7A1—asthma	1.9e-05	0.000273	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITPR1—asthma	1.88e-05	0.000269	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—RHOA—asthma	1.87e-05	0.000268	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLA2G4A—asthma	1.85e-05	0.000266	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTM1—asthma	1.85e-05	0.000266	CbGpPWpGaD
Valsartan—ALB—Metabolism—ARG2—asthma	1.82e-05	0.000261	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CD86—asthma	1.81e-05	0.00026	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL8—asthma	1.81e-05	0.00026	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—asthma	1.8e-05	0.000258	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EDN1—asthma	1.79e-05	0.000258	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL5—asthma	1.78e-05	0.000256	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2—asthma	1.78e-05	0.000255	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PLA2G4A—asthma	1.77e-05	0.000255	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CSF2—asthma	1.75e-05	0.000252	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLA2G4A—asthma	1.75e-05	0.000252	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CSF2—asthma	1.73e-05	0.000249	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2—asthma	1.73e-05	0.000248	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ARG1—asthma	1.72e-05	0.000247	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—asthma	1.71e-05	0.000246	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SMAD3—asthma	1.71e-05	0.000245	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPP2CA—asthma	1.7e-05	0.000245	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL8—asthma	1.64e-05	0.000236	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PPP2CA—asthma	1.63e-05	0.000235	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—HMOX1—asthma	1.63e-05	0.000234	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NQO1—asthma	1.62e-05	0.000233	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PPP2CA—asthma	1.61e-05	0.000232	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR5—asthma	1.6e-05	0.00023	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.6e-05	0.000229	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADCY2—asthma	1.59e-05	0.000228	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2RA—asthma	1.58e-05	0.000227	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.57e-05	0.000226	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2—asthma	1.57e-05	0.000225	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—C3—asthma	1.57e-05	0.000225	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2RA—asthma	1.56e-05	0.000224	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALDH7A1—asthma	1.55e-05	0.000223	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDGFB—asthma	1.53e-05	0.000219	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—VEGFA—asthma	1.51e-05	0.000217	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALOX15—asthma	1.51e-05	0.000217	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALOX5AP—asthma	1.51e-05	0.000217	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PDGFB—asthma	1.51e-05	0.000216	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ARG2—asthma	1.49e-05	0.000214	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CDK2—asthma	1.46e-05	0.00021	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLAU—asthma	1.46e-05	0.00021	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LEP—asthma	1.46e-05	0.00021	CbGpPWpGaD
Valsartan—ALB—Metabolism—CHAT—asthma	1.44e-05	0.000207	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—TGFB1—asthma	1.39e-05	0.000199	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FN1—asthma	1.38e-05	0.000198	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—asthma	1.37e-05	0.000197	CbGpPWpGaD
Valsartan—ALB—Hemostasis—FN1—asthma	1.36e-05	0.000195	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTP1—asthma	1.35e-05	0.000194	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—asthma	1.34e-05	0.000193	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HMOX1—asthma	1.33e-05	0.000192	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ITPR1—asthma	1.33e-05	0.000191	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAT—asthma	1.32e-05	0.000189	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—asthma	1.31e-05	0.000188	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.31e-05	0.000187	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALOX5—asthma	1.28e-05	0.000184	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—asthma	1.25e-05	0.00018	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLA2G4A—asthma	1.24e-05	0.000179	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTM1—asthma	1.24e-05	0.000179	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX15—asthma	1.23e-05	0.000177	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX5AP—asthma	1.23e-05	0.000177	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL2—asthma	1.23e-05	0.000176	CbGpPWpGaD
Valsartan—ALB—Metabolism—CARM1—asthma	1.22e-05	0.000176	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6R—asthma	1.22e-05	0.000176	CbGpPWpGaD
Valsartan—ALB—Metabolism—DCN—asthma	1.21e-05	0.000173	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EGFR—asthma	1.2e-05	0.000172	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—asthma	1.19e-05	0.000171	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CHAT—asthma	1.18e-05	0.000169	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALDH2—asthma	1.17e-05	0.000168	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPP2CA—asthma	1.15e-05	0.000164	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SERPINE1—asthma	1.15e-05	0.000164	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—asthma	1.14e-05	0.000164	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINE1—asthma	1.13e-05	0.000162	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—asthma	1.13e-05	0.000162	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTT1—asthma	1.12e-05	0.00016	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RHOA—asthma	1.1e-05	0.000159	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—asthma	1.09e-05	0.000157	CbGpPWpGaD
Valsartan—ALB—Hemostasis—RHOA—asthma	1.09e-05	0.000157	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—asthma	1.08e-05	0.000155	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX5—asthma	1.05e-05	0.000151	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—asthma	1.04e-05	0.00015	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CARM1—asthma	1e-05	0.000144	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DCN—asthma	9.87e-06	0.000142	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL8—asthma	9.7e-06	0.000139	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALDH2—asthma	9.6e-06	0.000138	CbGpPWpGaD
Valsartan—ALB—Metabolism—NQO1—asthma	9.27e-06	0.000133	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2—asthma	9.27e-06	0.000133	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	9.23e-06	0.000133	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—asthma	9.22e-06	0.000132	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2—asthma	9.16e-06	0.000131	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTT1—asthma	9.13e-06	0.000131	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTEN—asthma	9.1e-06	0.000131	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADCY2—asthma	9.07e-06	0.00013	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—asthma	9e-06	0.000129	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—asthma	8.79e-06	0.000126	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—asthma	8.77e-06	0.000126	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTEN—asthma	8.72e-06	0.000125	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	8.42e-06	0.000121	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—asthma	8.01e-06	0.000115	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VEGFA—asthma	7.88e-06	0.000113	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTEN—asthma	7.84e-06	0.000113	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—STAT3—asthma	7.8e-06	0.000112	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VEGFA—asthma	7.78e-06	0.000112	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTP1—asthma	7.73e-06	0.000111	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—asthma	7.67e-06	0.00011	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMOX1—asthma	7.63e-06	0.000109	CbGpPWpGaD
Valsartan—ALB—Metabolism—ITPR1—asthma	7.61e-06	0.000109	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NQO1—asthma	7.59e-06	0.000109	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAT—asthma	7.52e-06	0.000108	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADCY2—asthma	7.43e-06	0.000107	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	7.36e-06	0.000106	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFB1—asthma	7.23e-06	0.000104	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TGFB1—asthma	7.14e-06	0.000103	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLA2G4A—asthma	7.11e-06	0.000102	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM1—asthma	7.11e-06	0.000102	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EGFR—asthma	7.09e-06	0.000102	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—asthma	7.01e-06	0.000101	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPP2CA—asthma	6.54e-06	9.39e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	6.42e-06	9.22e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTP1—asthma	6.33e-06	9.09e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMOX1—asthma	6.24e-06	8.96e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ITPR1—asthma	6.23e-06	8.94e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAT—asthma	6.16e-06	8.84e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTEN—asthma	6.11e-06	8.78e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLA2G4A—asthma	5.82e-06	8.35e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM1—asthma	5.82e-06	8.35e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—asthma	5.45e-06	7.82e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPP2CA—asthma	5.36e-06	7.69e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—asthma	5.02e-06	7.21e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—asthma	4.38e-06	6.29e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—asthma	4.11e-06	5.9e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—asthma	4.01e-06	5.75e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—asthma	3.75e-06	5.38e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—asthma	3.59e-06	5.15e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTEN—asthma	3.49e-06	5.02e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—asthma	3.28e-06	4.71e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTEN—asthma	2.86e-06	4.11e-05	CbGpPWpGaD
